Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Curcumin Acts as a Positive Allosteric Modulator of α7-Nicotinic Acetylcholine Receptors and Reverses Nociception in Mouse Models of Inflammatory Pain.
El Nebrisi EG
,
Bagdas D
,
Toma W
,
Al Samri H
,
Brodzik A
,
Alkhlaif Y
,
Yang KS
,
Howarth FC
,
Damaj IM
,
Oz M
.
???displayArticle.abstract???
Effects of curcumin, a major ingredient of turmeric, were tested on the function of the α7-subunit of the human nicotinic acetylcholine (α7-nACh) receptor expressed in Xenopus oocytes and on nociception in mouse models of tonic and visceral pain. Curcumin caused a significant potentiation of currents induced by acetylcholine (ACh; 100 μM) with an EC50 value of 0.2 µM. The effect of curcumin was not dependent on the activation of G-proteins and protein kinases and did not involve Ca2+-dependent Cl- channels expressed endogenously in oocytes. Importantly, the extent of curcumin potentiation was enhanced significantly by decreasing ACh concentrations. Curcumin did not alter specific binding of [125I]α-bungarotoxin. In addition, curcumin attenuated nociceptive behavior in both tonic and visceral pain models without affecting motor and locomotor activity and without producing tolerance. Pharmacological and genetic approaches revealed that the antinociceptive effect of curcumin was mediated by α7-nACh receptors. Curcumin potentiated the antinociceptive effects of the α7-nACh receptor agonist N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU282987). Collectively, our results indicate that curcumin is a positive allosteric modulator of α7-nACh receptor and reverses nociception in mouse models of tonic and visceral pain.
Abbott,
The formalin test: scoring properties of the first and second phases of the pain response in rats.
1995, Pubmed
Abbott,
The formalin test: scoring properties of the first and second phases of the pain response in rats.
1995,
Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed
Anand,
Bioavailability of curcumin: problems and promises.
2007,
Pubmed
Bagdas,
The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in Mice.
2015,
Pubmed
Bagdas,
The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain.
2016,
Pubmed
Bagdas,
New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs.
2018,
Pubmed
Banderali,
Curcumin blocks Kv11.1 (erg) potassium current and slows proliferation in the infant acute monocytic leukemia cell line THP-1.
2011,
Pubmed
Brauneis,
Differential sensitivity of recombinant N-methyl-D-aspartate receptor subunits to inhibition by dynorphin.
1996,
Pubmed
,
Xenbase
Chatzidaki,
Allosteric modulation of nicotinic acetylcholine receptors.
2015,
Pubmed
Choi,
Class 3 inhibition of hERG K+ channel by caffeic acid phenethyl ester (CAPE) and curcumin.
2013,
Pubmed
Davidson,
Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors.
1998,
Pubmed
Dyer,
Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor.
2002,
Pubmed
Enyeart,
Curcumin inhibits ACTH- and angiotensin II-stimulated cortisol secretion and Ca(v)3.2 current.
2009,
Pubmed
Enyeart,
Curcumin inhibits bTREK-1 K+ channels and stimulates cortisol secretion from adrenocortical cells.
2008,
Pubmed
Freitas,
The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models.
2013,
Pubmed
Freitas,
Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.
2013,
Pubmed
Gee,
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288.
2017,
Pubmed
Goozee,
Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
2016,
Pubmed
Hartzell,
Calcium-activated chloride channels.
2005,
Pubmed
Hogg,
Nicotinic acetylcholine receptors: from structure to brain function.
2003,
Pubmed
Hone,
Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.
2018,
Pubmed
Hong,
The inhibitory effect of curcumin on voltage-dependent K⁺ channels in rabbit coronary arterial smooth muscle cells.
2013,
Pubmed
Hu,
Curcumin inhibits hERG potassium channels in vitro.
2012,
Pubmed
Hunskaar,
The formalin test in mice: dissociation between inflammatory and non-inflammatory pain.
1987,
Pubmed
Ibrahim,
Curcumin induces apoptosis in a murine mammary gland adenocarcinoma cell line through the mitochondrial pathway.
2011,
Pubmed
Ji,
The multiple pharmaceutical potential of curcumin in Parkinson's disease.
2014,
Pubmed
Kunnumakkara,
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.
2017,
Pubmed
Li,
The effects of dietary and herbal phytochemicals on drug transporters.
2017,
Pubmed
Lian,
Curcumin serves as a human kv1.3 blocker to inhibit effector memory T lymphocyte activities.
2013,
Pubmed
Liu,
Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling.
2016,
Pubmed
Liu,
Inhibition of L-type Ca(2+) channels by curcumin requires a novel protein kinase-theta isoform in rat hippocampal neurons.
2013,
Pubmed
Liu,
Curcumin potently blocks Kv1.4 potassium channels.
2006,
Pubmed
Mahgoub,
Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase
Mahmmoud,
Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions.
2007,
Pubmed
Milani,
Carotenoids: biochemistry, pharmacology and treatment.
2017,
Pubmed
Mittal,
Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat.
2009,
Pubmed
Morales,
Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches.
2014,
Pubmed
Moustapha,
Curcumin induces crosstalk between autophagy and apoptosis mediated by calcium release from the endoplasmic reticulum, lysosomal destabilization and mitochondrial events.
2015,
Pubmed
Munro,
The α7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat.
2012,
Pubmed
Onaran,
Allosteric coupling and conformational fluctuations in proteins.
2009,
Pubmed
Oz,
Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.
2004,
Pubmed
,
Xenbase
Oz,
Angiotensin AT(1)-receptors depolarize neonatal spinal motoneurons and other ventral horn neurons via two different conductances.
2002,
Pubmed
Oz,
Functional coupling of human L-type Ca2+ channels and angiotensin AT1A receptors coexpressed in xenopus laevis oocytes: involvement of the carboxyl-terminal Ca2+ sensors.
1998,
Pubmed
,
Xenbase
Oz,
The solubilizing detergents, Tween 80 and Triton X-100 non-competitively inhibit alpha 7-nicotinic acetylcholine receptor function in Xenopus oocytes.
2004,
Pubmed
,
Xenbase
Pérez-Lara,
Curcumin modulates PKCα activity by a membrane-dependent effect.
2011,
Pubmed
Sands,
Barium permeability of neuronal nicotinic receptor alpha 7 expressed in Xenopus oocytes.
1993,
Pubmed
,
Xenbase
Shoba,
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.
1998,
Pubmed
Spagnuolo,
Neuroprotective Role of Natural Polyphenols.
2016,
Pubmed
Spivak,
The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors.
2007,
Pubmed
Tajik,
The effect of curcumin (active substance of turmeric) on the acetic acid-induced visceral nociception in rats.
2008,
Pubmed
Takikawa,
Curcumin stimulates glucagon-like peptide-1 secretion in GLUTag cells via Ca2+/calmodulin-dependent kinase II activation.
2013,
Pubmed
Thomsen,
Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology.
2010,
Pubmed
Umana,
Neuronal nicotinic receptors as analgesic targets: it's a winding road.
2013,
Pubmed
Uteshev,
The therapeutic promise of positive allosteric modulation of nicotinic receptors.
2014,
Pubmed
Uteshev,
α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.
2012,
Pubmed
Wang,
Curcumin-induced apoptosis in human hepatocellular carcinoma j5 cells: critical role of ca(+2)-dependent pathway.
2012,
Pubmed
Yang,
Oral curcumin has anti-arthritic efficacy through somatostatin generation via cAMP/PKA and Ca(2+)/CaMKII signaling pathways in the small intestine.
2015,
Pubmed
Yeon,
Curcumin produces an antihyperalgesic effect via antagonism of TRPV1.
2010,
Pubmed
Zhang,
Effects of curcumin on ion channels and transporters.
2014,
Pubmed
Zhi,
Curcumin acts via transient receptor potential vanilloid-1 receptors to inhibit gut nociception and reverses visceral hyperalgesia.
2013,
Pubmed
Zhou,
The targets of curcumin.
2011,
Pubmed
